Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Details) - Schedule of warrant activities

v3.22.1
Shareholders' Deficit (Details) - Schedule of warrant activities - Warrant [Member]
3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]  
Number of Warrants, Balance Outstanding, Beginning | shares 17,500,000
Weighted Average Exercise Price, Balance Outstanding, Beginning | $ / shares $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning 4 years 8 months 1 day
Aggregate Intrinsic Value, Balance Outstanding, Beginning | $
Number of Warrants, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Weighted Average Remaining Contractual Term (Years), Granted
Aggregate Intrinsic Value, Granted | $
Number of Warrants, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised | $
Number of Warrants, Balance Outstanding, Ending | shares 17,500,000
Weighted Average Exercise Price, Balance Outstanding, Ending | $ / shares $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 4 years 5 months 1 day
Aggregate Intrinsic Value, Balance Outstanding, Ending | $
Number of Warrants, Exercisable | shares 17,500,000
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.05
Weighted Average Remaining Contractual Term (Years), Exercisable 4 years 5 months 1 day
Aggregate Intrinsic Value, Exercisable | $